This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: The Florida State University Research Foundation, Inc., Florida International University. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2025
Title: Branko Stefanovic: Innovator in Antifibrotic Research
Introduction
Branko Stefanovic is a notable inventor based in Tallahassee, FL (US). He has made significant contributions to the field of antifibrotic research, holding a total of 6 patents. His work focuses on compositions and methods that inhibit type 1 collagen production, which is crucial in the treatment of fibrosis.
Latest Patents
Stefanovic's latest patents include "Compositions and methods for inhibiting type 1 collagen production." This patent discloses that compounds of Formula 1 may be used as antifibrotics because they inhibit type 1 collagen production. It particularly details a pharmaceutical composition containing one or more compounds of Formula 1 and methods of using these compounds in fibrosis treatment and inhibiting type 1 collagen synthesis. Another significant patent is "Antifibrotic compounds and related methods," which also highlights the antifibrotic properties of compounds of Formula 1. This patent emphasizes a pharmaceutical composition that includes one or more compounds of Formula 1 and methods for their application in fibrosis treatment.
Career Highlights
Throughout his career, Branko Stefanovic has worked with esteemed institutions such as the Florida State University Research Foundation, Inc. and Florida International University. His research has been pivotal in advancing the understanding of antifibrotic treatments.
Collaborations
One of his notable collaborators is Adel Nefzi, with whom he has worked on various research projects.
Conclusion
Branko Stefanovic's innovative work in antifibrotic research has led to significant advancements in the treatment of fibrosis. His contributions are reflected in his patents and collaborations, marking him as a key figure in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
